Chancroid
Infectious Disease
Chancroid is treated with 1 medication in our database, including SULFADIAZINE. Medications are manufactured by Lannett. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Chancroid treatment below.
What help exists for Chancroid
17
drugs indexed
5
with copay cards
5
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Chancroid
17 totalDoxycycline Hyclate
doxycycline hyclate Β· Pfizer
ππDoxycycline Monohydrate
Doxycycline Monohydrate
DOXY 100(TM) DOXYCYCLINE
Fresenius Kabi
Tetracycline Hydrochloride
Tetracycline Hydrochloride Β· Breckenridge Pharmaceutical, Inc.
Minocycline Hydrochloride
minocycline hydrochloride Β· Bausch Health
Doxycyclate Hyclate
Doxycycline Hyclate
ππDOXYCYCLINE HYCLATE DELAYED RELEASE
doxycycline hyclate
ππTARGADOX
doxycycline hyclate Β· Journey Medical
AZITHROMYCIN
Azithromycin Β· Pfizer
SULFADIAZINE
sulfADIAZINE Β· Lannett
DORYX MPC
doxycycline hyclate Β· Mayne Pharma
ππDoxycycline
doxycycline Β· Pfizer
Doxy 100
DOXYCYCLINE Β· Fresenius Kabi USA, LLC
DOXYCYCLINE DOXYCYCLINE
DOXYCYCLINE
Acticlate CAP
doxycycline hyclate Β· Almirall, LLC
Demeclocycline Hydrochloride
Demeclocycline
AZITHROMYCIN DIHYDRATE
Azithromycin dihydrate Β· Pfizer
ππ
π = copay card Β· π = patient assistance program
Prior authorization patterns for Chancroid drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
Showing 10 of 25 PA rules for Chancroid drugs. View individual drug pages for complete PA detail.